drugset / Trial / NCT04906772
Dexmedetomidine-ketamine Versus Propofol-ketamine for Sedation During Endoscopy in Hepatic Patients
RandomizedParallel-groupTriple-blindTreatment
Summary
We aim to compare the response to ketamine/dexmedetomidine and ketamine/propofol combinations used in hepatic patients with child-Pugh classification (class A), and early (class B) undergoing UGIE.
Timeline
- Start
- 2021-02-03
- Primary completion
- 2021-07-13
- Completion
- 2021-09-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dexmedetomidine | Other / unclassified | 0.25 ug/kg | Intravenous |
| Comparator | Propofol | Small molecule | 0.25 mg/kg | Intravenous |
| Background | Ketamine | Small molecule | 0.25 mg/kg | Intravenous |
Indications
No indication recorded.